Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
1.9100
0.0000
(0.00%)
At close: February 27 at 5:29:31 PM GMT+1
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-124,200
-124,200
-59,700
-101,820
-48,734
Investing Cash Flow
--
--
-300
-382
--
Financing Cash Flow
17,200
17,200
112,100
-1,535
199,400
End Cash Position
62,500
62,500
169,500
117,434
221,167
Capital Expenditure
--
--
-300
-382
--
Issuance of Capital Stock
20,400
20,400
129,700
404
223,515
Repayment of Debt
--
--
-1,977
-1,940
-2,475
Free Cash Flow
-124,200
-124,200
-60,000
-102,202
-48,734
12/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EGTX.ST Egetis Therapeutics AB (publ)
5.07
+0.20%
TLOG TetraLogic Pharmaceuticals Corporation
0.0001
0.00%
PEG.CO Pharma Equity Group A/S
0.1435
+0.70%
IRLAB-A.ST IRLAB Therapeutics AB (publ)
14.50
-1.36%
VICO.ST Vicore Pharma Holding AB (publ)
8.24
+0.49%
XBRANE.ST Xbrane Biopharma AB (publ)
0.1544
-0.26%
ACE.ST Ascelia Pharma AB (publ)
3.5150
-0.42%
DMYD-B.ST Diamyd Medical AB (publ)
15.80
+0.51%
IKNA Ikena Oncology, Inc.
1.3700
0.00%
ATORX.ST Alligator Bioscience AB (publ)
0.1080
-10.60%